1. Product Overview
2. Research Methodology
3. Impact of COVID-19
on Clindamycin Phosphate Market
4. Executive Summary
5. Manufacturing Clindamycin
Phosphate
5.1.
Raw Material
5.2.
Machinery
5.3.
Manufacturing Methods
5.4.
Contact Details of Machinery & Raw Material Suppliers
6. Pharmacodynamic
Overview of Clindamycin Phosphate
6.1.
Mechanism of Action
6.2.
Absorption
6.3.
Volume of Distribution
6.4.
Protein Binding
6.5.
Metabolism
6.6.
Route of Elimination
6.7.
Half-Life
6.8.
Clearance
6.9.
Toxicity
7. India Clindamycin
Phosphate Market Outlook
7.1.
Market Size & Forecast
7.1.1. By Value &
Volume
7.2.
Market Share & Forecast
7.2.1. By Product Type
(Prescription v/s OTC)
7.2.2. By Source (In-house
v/s Contract Manufacturing Organizations)
7.2.3. By Form (Gel,
Topical Solution, Foam, Injection, Others)
7.2.4. By Gender (Men v/s
Women)
7.2.5. By Distribution
Channel (Online v/s Offline)
7.2.6. By Application (Acne
Vulgaris, Genito-Urinary Infections, Pseudomembranous Colitis, Others)
7.2.7. By Region (North,
East, South, West)
7.2.8. By Company
7.3.
Product Market Map
8.
Market Dynamics
8.1.
Drivers/Opportunities
8.2.
Challenges/Restraints
9.
Market Trends & Developments
10.
Policy & Regulatory Landscape
10.1.
Custom Duty & Taxes
10.2.
Government Subsidy & Benefits
10.3.
Relevant Policies & Regulations (GMP, USFDA, WHO
Certifications)
11.
Import & Export Analysis
12.
Pricing Analysis
13.
India Economic Profile
14.
Competitive Landscape
14.1.
Company Profiles
14.1.1. Mylan
Pharmaceuticals Private Limited
14.1.1.1. Company Brief
14.1.1.2. Production Plants
& Capacity (If Available)
14.1.1.3. Financials (If
Available)
14.1.1.4. Captive Consumption
Vs Merchant Sale
14.1.1.5. Current & Future
Plans
14.1.2. Midas Care
Pharmaceuticals Pvt. Ltd.
14.1.3. Taro Pharmaceuticals
India Private Limited
14.1.4. Alvogen Pharma India
Pvt. Ltd.
14.1.5. Fresenius Kabi India
Pvt. Ltd.
14.1.6. Akorn India Pvt.
Ltd.
14.1.7. Cadila
Pharmaceuticals
14.1.8. Perrigo India Pvt.
Ltd.
14.1.9. Sun Pharmaceuticals
Industries Ltd.
14.1.10.
Alvogen Pharma India Pvt. Ltd.
15.
Strategic Recommendations
16.
About Us & Disclaimer